Adult respiratory distress syndrome and its management.
ARDS is a relatively common disorder whose high mortality has changed little over the past few years. Management remains supportive in essence, consisting of careful ventilatory management and attention to fluid balance and nutritional needs. Certain complications, especially sepsis, need to be prevented if possible. Currently, there is no pharmacologic intervention of proven benefit. Future improvements in the treatment of ARDS will depend on new research incorporating both laboratory and clinical approaches.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D005227:Fatty Acids / Q000627:therapeutic use; D005440:Fluid Therapy; D006471:Gastrointestinal Hemorrhage / Q000517:prevention & control; D006801:Humans; D011379:Prognosis; D012121:Respiration, Artificial; D012128:Respiratory Distress Syndrome / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D012306:Risk; D013923:Thromboembolism / Q000517:prevention & control
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D000975:Antioxidants; D005227:Fatty Acids